Investigation of the Interaction of Antitumor Palladium and Platinum Complexes of Ethyldithiocarbamate with Human Serum Albumin

Document Type : Research Article


1 Chemistry & Chemical Engineering Research Center of Iran. Tehran, I.R. IRAN

2 Department of Chemistry, University of Sistan and Baluchestan, Zahedan, I.R. IRAN

3 Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Karaj, I.R. IRAN


In this work, two Platinum (II) and Palladium (II) complexes of 2,2'-bipyridine (bpy) and diethyldithiocarbamate (Et-dtc) with anti-tumor activity against K562 were selected. The Cc50 values of Pd and Pt compounds are 55 and 89 micromolar, respectively that are lower than cisplatin. These complexes interacted with human serum albumin (HSA) in Tris-buffer containing 10 mM NaCl, pH=7.4 at 27 and 37 °C by spectroscopic methods. Results obtained from denaturation studies indicate that probably Pd(II) complex denature the HSA while the Pt(II) does not so. Isothermal titration data indicated that the stability of protein decrease by increasing complex concentration and the denaturation process is exothermic. Binding of these cationic complexes with HSA occurs by electrostatic interaction. These complexes can denature HSA at very low concentrations of the micromolar spatially platinum complex. Fluorescence studies showed the intensity of HSA quenched in the presence of each Pt or Pd complex and quenching mechanism seems to be static. Circular dichroism spectra of HSA were recorded and the percentage of alpha helicity in the presence of Pd and Pt complexes were investigated 5 and 3%, respectively.


Main Subjects

[1] Yang N., Sheridan A.M., “Reference Module in Biomedical Sciences Encyclopedia of Toxicology”, 4th ed., USA, Elsevier, 753–758 (2013).
[2] منصوری ترشیزی، حسن؛ جهانگیری، سمیرا؛ بابایی زاچ، ملیحه؛ خدابخشی کنگان، زهرا؛ نزشتی، فریده؛ حیدری مجد، مصطفی؛ تهیه، شناسایی، ویژگی‌های ضدتومور، برهم‏کنش با DNA و تأثیر بار الکتریکی موجود روی نسبت‏های مولی گوناگون کمپلکس‏های Pd(II):Zn(II) در "ترکیب درمانی" آن‏ها، نشریه شیمی و مهندسی شیمی ایران، (2)36: 55 تا 69 (1396).
[3] Imran A., Waseem A.W., Kishwar S., Ashanul H., Platinum Compounds: A Hope for Future Cancer ChemotherapyAnti-Cancer Agents Med. Chem.13: 296-306 (2013).
[4] Kelland L., The Resurgence of Platinum-Based Cancer ChemotherapyJ. Appl. Biomed.7: 573-584 (2007).
[5] Abramkin S.A., Berger W., Jungwirth U., Jakupec M.A., Valiahdi S.M., Hartinger C.G., Dworak C., Nazarov A.A., Habala L., Meelich K., Galanski M., Keppler B.K., {(1R,2R,4R)-4-Methyl-1,2-cyclohexanediamine} oxalatoplatinum(II): A Novel Enantiomerically Pure Oxaliplatin Derivative Showing Improved Anticancer Activity in VivoJ. Med. Chem. 53: 7356–7364 (2010).
[6] Trudu F., Amato F., Vaňhara P., Pivetta T., Peña-Méndez E.M., Havel J., Coordination compounds in cancer: Past, Present and  PerspectivesJ. Appl. Biomed., 13: 79-103 (2015).
[7]   Knuutila S., Aalto Y., Autio K., Björkqvist A.M., El-Rifai W., Hemmer S., Huhta T., Kettunen E., Kiuru-Kuhlefelt S., Larramendy M.L., Lushnikova T., Monni O., Pere H., Tapper J., Tarkkanen M., Varis A., Wasenius V.M., Wolf M., Zhu Y., DNA Copy Number Losses in Human Neoplasms, American Journal of Pathology, 155: 683-694 (1999).
[8] Jain N., Paul A.K., Srivastava T.S., Synthesis, Characterization, Cytotoxicity and DNA Binding Studies of Diamminediethyldithiocarbamato-Platinum(II) NitrateJ. Inorg. Biochem., 45(2): 123-127 (1992).
[9] Eslami Moghadam, M., Saidifar, M., Divsalar, A., Mansouri-Torshizi, H., Saboury, A. A., Farhangian, H., & Ghadamgahi, M. Rich Spectroscopic and Molecular Dynamic Studies on the Interaction of Cytotoxic Pt (II) and Pd (II) Complexes of Glycine Derivatives with Calf Thymus DNA, Journal of Biomolecular Structure and Dynamics, 34(1): 206-222 (2016).
[10] MansouriTorshizi H., IslamiMoghaddam M., Saboury A.A., A Microcalorimetry and Spectroscopy Study on the Interaction of Bovine Serum Albumin with 2,2›-bipyridine octylglycinato Palladium (II) NitrateActa Bioch. Bioph. Sin. (ABBS), 35(10): 886-890 (2003).
[11] Eslami Moghadam M., Divsalar A., Abolhosseini Shahrnoy A., Saboury, A.A. Synthesis, Cytotoxicity Assessment, and Interaction and Docking of Novel Palladium(II) Complexes of Imidazole Derivatives with Human Serum AlbuminJ. Biomol. Struct. Dyn.34(8): 1751–1762 (2016).
[12] Holford J., Beale P.J., Boxall F.E., Mechanism of Drug Resistance to the Platinum Complex ZD0473 in Ovarian Cell LineEur. J. Cancer36(15): 1984-1990 (2000).
[13] Kantoury M., Eslami Moghadam M., Tarlani A.A., Divsalar A., Structure Effect of Some New Anticancer Pt (II) Complexes of Amino Acid Derivatives with Small Branched or Linear Hydrocarbon Chains on Their DNA InteractionChemical Biology & Drug Design, 88(1): 76-87 (2016).
[14] Islami-Moghaddam M., Mansouri-Torshizi H., Divsalar A., Saboury A.A., Synthesis, Characterization, Cytotoxic and DNA Binding Studies of Diimine Platinum(II) and Palladium(II) Complexes of Short Hydrocarbon Chain Ethyldithiocarbamate LigandJ. Iran. Chem. Soc., 6(3): 552-569 (2009).
[15] Saeidifar M., Mansouri-Torshizi H., Palizdar Y., Eslami-Moghaddam M., Divsalar A., Saboury A.A., Synthesis, Characterization, Cytotoxicity and DNA Binding Studies of a Novel Anionic Organopalladium (II) ComplexActa Chimica Slovenica, 61(1): 126-36 (2014).
[16] Mansouri-Torshizi H., I-Moghaddam M., Divsalar A., Saboury A.A., 2,2 -Bipyridinebutyldithiocarbamatoplatinum(II) and Palladium(II) Complexes: Synthesis,  Characterization, Cytotoxicity, and Rich DNA-Binding StudiesBioorg. Med. Chem., 16: 9616-9625 (2008).
[17] Mansouri-Torshizi H., Divsalar A., Eslami-Moghadam M., Saboury A.A., DNA-Binding Studies of Some Potential Antitumor 2,2'–bipyridine Pt(II)/Pd(II) Complexes of Piperidinedithiocarbamate. Their Synthesis, Spectroscopy and CytotoxicityActa Chim. Slov58: 811–822 (2011).
[18] Ajloo D., Eslami Moghadam M., Ghadimi K., Ghadamgahi  M., Saboury A.A., Divsalar A., Sheikh Mohammadi M., Yousefi K., Synthesis, Characterization, Spectroscopy, Cytotoxic Activity and Molecular Dynamic Study on the Interaction of Three Palladium Complexes of Pphenanthroline and Glycine Derivatives with Calf Thymus DNAInorg. Chim. Acta430: 144-160 (2015).
[19] Wakasa M., Takamori Y., Takayanagi T., Orihara M., Kugita T., Re-Examination of the Photochemical Reaction of Octaisopropylcyclotetragermane, J. Organomet. Chem.692(14): 2855–2860 (2007).
[20] اسمعیل­زایی، زهره؛ صبوری، علی اکبر؛ منصوری­ترشیزی، حسن؛ سعیدی­فر، مریم؛ دیوسالار، عادله؛ مطالعه برهمکنش کمپلکس های نیکل، (II) دارای لیگاندهای آروماتیک مسطح با DNA غده تیموس، نشریه شیمی و مهندسی شیمی ایران، (2)32: 1 تا 13 (1392).
[20] Esmaeilzaei Z., Saboury A.A., Mansouri Torshizi H., Saeidifar M., Divsalar A., Studies of the Interaction of Ni (II) Complexes Bearing Planar Aromatic Ligands with Calf Thymus DNANashrieh Shimi va Mohandesi Shimi Iran, 32(2): 1 (2013).
[21] Shahraki S., Mansouri-Torshizi H., Heydari A., Ghahghaei A., Divsalar A., Saboury A., Zareian S., Platinum (II) and Palladium (II) Complexes with 1, 10-Phenanthroline and Pyrrolidinedithiocarbamato Ligands: Synthesis, DNA-Binding and Anti-Tumor Activity in Leukemia K562 Cell LinesIranian Journal of Science and Technology, 39(A2): 187 (2015).
[22] Mandal P., Bardhan M., Ganguly T., A Detailed Spectroscopic Study on the Interaction of Rhodamine 6G with Human HemoglobinJ. Photochem. Photobiol. B Biol., 99(2): 78–86 (2010).
[23] Divsalar A., Khodabakhshian S., Probing the Binding Site of a New Synthesized Anti-Cancer Compound to HSA via Competitive Ligand Binding MethodJ. Mol. Liq.206: 82–88 (2015).
[24] Dockal M., Cater D.C., Rüker F., The Three Recombinant Domains of Human Serum Albumin, Structural Characterization and Ligand Binding PropertiesJ. Biol. Chem., 274(41): 29303–29310 (1999).
[25] Topala T., Bodoki A., Oprean L., Oprean R., Experimental Techniques Employed in the Study of Metal Complexes-DNA InteractionsFarmacia, 62(6): 1049–1061 (2014).